Related Experiment Video
Updated: May 3, 2026

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Improving antibiotic prescribing for children in the resource-poor setting
Kirsty Le Doare1, Charlotte I S Barker, Adam Irwin
1Paediatric Infectious Diseases Research Group, St George's University of London, Cranmer Terrace, London, SW17 0RE, UK; Wellcome Trust Centre for Global Health Research, Imperial College, Norfolk Place, London, W2 1NY, UK.
Antibiotic use in low- and middle-income countries (LMICs) is vital for child health but often inappropriate. Improving prescribing practices requires better access to medicines and evidence-based guidelines to combat antimicrobial resistance.
Area of Science:
- Global Health
- Pediatric Pharmacology
- Antimicrobial Stewardship
Background:
- Antibiotics are essential for treating infectious diseases, the primary cause of mortality in children in low- and middle-income countries (LMICs).
- Inappropriate antibiotic use, including incorrect prescribing and patient adherence, is widespread globally, contributing to antimicrobial resistance.
- LMICs face significant challenges in implementing policies for rational antibiotic use in pediatric care.
Purpose of the Study:
- To provide an overview of the challenges and strategies for rational antibiotic prescribing in pediatric populations within LMICs.
- To highlight the impact of inappropriate antibiotic use on antimicrobial resistance and child mortality.
- To discuss future developments that could enhance antibiotic prescribing in LMICs.
Main Methods:
- Review of existing literature and World Health Organization (WHO) initiatives related to pediatric medicine use in LMICs.
- Analysis of barriers to rational antibiotic prescribing in resource-limited settings.
- Discussion of strategies for improving access to appropriate medications and clinical guidelines.
Main Results:
- Inappropriate antibiotic use is a major concern in LMICs, exacerbating antimicrobial resistance.
- WHO initiatives like 'Make medicines child size' are crucial steps but require continued support.
- Persistent barriers hinder the effective implementation of rational prescribing policies.
Conclusions:
- Improving access to appropriate pediatric formulations and strengthening evidence-based guidelines are essential for rational antibiotic use in LMICs.
- Addressing inappropriate antibiotic use is critical to combatting antimicrobial resistance and reducing child mortality.
- Future developments must focus on sustainable strategies to enhance pediatric antibiotic prescribing in resource-limited settings.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Mechanism of Antibiotic Resistance in MRSA
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Antibiotic Selection

